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According to WHO cardiovascular diseases (CVDs) are the first cause of death in the world: more people die 
annually from CVDs than from any other cause. Vascular endothelium plays a pivotal role in the onset and 
progression of these pathologies and cardiovascular risk factors are frequently associated to the levels of 
endothelial progenitor cells (EPCs), bone marrow-derived circulating progenitors for the endothelial lineage. 
Since EPCs not only preserve vascular endothelium homeostasis, but might directly participate to 
re-endothelization and neovascularization, these cells represent an emerging protagonist in vascular competency 
and as such a cell model of great interest. An unhealthy diet is one of the main cardiovascular risk factor, while 
there is a great interest in the potential protective effects of "nutraceuticals", food-derived compounds that exert 
beneficial effects on human and animal health. The characterization of the endothelial effects of different 
nutraceuticals may provide fresh insights into their potential role in CVDs prevention. Several studies have 
already showed the protective effects of natural antioxidants on EPCs levels and functionality; some examples 
are resveratrol, catechin and folic acid. Fermentation has recently shown interesting roles in cardiovascular 
prevention since this process gave origin to a new class of foods, rich in bioactive compounds, the fermented 
foods. Consumption of fermented legumes and cereals, but also fermented beverages (such as beer and wine) was 
found to protect endothelial function through both lipid-lowering, as well anti-inflammatory and antioxidative 
mechanisms. Little is known about the effects of fermentation-derived nutraceuticals on EPCs. Given the 
important role of this cardiovascular biomarker, further analysis in this field can improve opportunities for 
CVDs prevention and treatment. 
Keywords: endothelial function; endothelial progenitor cells; diet; antioxidants; cardiovascular diseases 
To cite this article: R. Russo, et al. Nutraceuticals and cardiovascular risk: potential role of EPCs modulation. Stem Cell 
Transl Investig 2015; 2: e949. doi: 10.14800/scti.949. 
 
Vascular endothelium and EPCs: new insights 
For many years vascular endothelium has been considered 
a mere physical barrier between blood and underlying 
tissues; recent studies have demonstrated new and interesting 
roles of endothelium in vascular health [1]. 
Endothelial cells composing this monolayer have therefore 
paracrine, endocrine and autocrine functions, by secreting 
several factors with vasodilatory and antiproliferative effects, 
such as endothelium-derived hyperpolarization factor 
(EDHF), nitric oxide (NO) and prostacyclin (PGI2), and 
others inducing vasoconstrictor response, for instance 
endothelin-1 (ET-1), angiotensin II and reactive oxygen 
species (ROS) [2]. 
These evidences make the vascular endothelium a 
multifunctional unit that regulates vascular homeostasis by 
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maintaining the equilibrium between vasodilation and 
vasoconstriction; when this finely regulated balance is 
compromised, endothelium dysfunction occurs. 
Beyond setting of vascular tone and integrity, the 
maintenance of vascular health includes also regulation of 
angiogenesis, hemostasis, immune and inflammatory 
responses, vascular growth and remodeling [2].  
One key actor in vascular repair and homeostasis, is the 
endothelial progenitor cell (EPC) system, bone 
marrow-derived circulating progenitors for the endothelial 
lineage, first described in 1997 by Asahara and colleagues [3]. 
EPCs circulate from bone marrow to incorporate into 
vascular endothelium and thus contribute to postnatal 
physiological and pathological neovascularization [4]. EPCs 
not only ensure the correct turnover of endothelial cells, but 
are also involved in the development, repair and regeneration 
of the systemic vasculature, as demonstrated by Prater and 
colleagues [5]. Indeed, in this study, authors suggest that 
postnatal neovascularization does not rely exclusively on 
sprouting from preexisting blood vessels (angiogenesis). 
During the last decade, significant research has been 
performed to elucidate the physiological role of EPCs in 
tissue repair and to correlate these cells to several disease 
states. 
EPCs are mainly located within the stem cell niche in 
bone marrow, along with some circulating populations in the 
peripheral blood. The process by which EPCs contribute to 
new vessel formation in adults consists of four interrelated 
steps. When injury or tissue damage occurs, EPCs are 
mobilized from the bone marrow into the circulation and 
home to tissue repair sites under the induction of signals such 
as hypoxia, growth factors, chemoattractant, and 
chemokines. EPCs then invade and migrate at the same sites, 
and differentiate into mature endothelial cells (ECs) and/or 
regulate pre-existing ECs via paracrine or juxtacrine signals 
[6]. These progenitors also improved the activity of 
endothelial NO synthase (eNOS), thereby restoring the 
correct functionality of endothelium [7, 8]. The success of each 
step depends on the ability of EPCs to interact, adapt, and 
respond to multiple molecular stimuli [9]. 
Thus EPCs, playing an important role in endothelium 
maintenance, re-endothelialization and neovascularization, 
represent an emerging actor involved in vascular fitness and 
as such a cell model of great interest [4]. 
Despite the great enthusiasm aroused by these cells, 
several areas of controversy still persist in the study of EPCs, 
related to their identification, characterization and effective 
role in vascular biology. In particular, the lack of an unique 
and specific EPCs marker and the functional and 
phenotypical overlap between these cells and hematopoietic 
and mature endothelial cells, make it very difficult and 
controversial to define EPCs real identity [10]. 
Endothelium dysfunction and cardiovascular diseases: 
role of EPCs 
Functional impairment of vascular endothelium is found in 
cardiovascular diseases [11] and also in patients with type 2 
diabetes, insulin resistance and obesity [12]; therefore the 
integrity and functional properties of the endothelial 
monolayer play a critical role in atherogenesis, while 
cardiovascular risk factors induce endothelial injury and a 
cascade of pro-inflammatory events [13]. 
As mentioned before endothelium dysfunction is caused 
by an imbalance between vasoconstrictor and vasodilator 
molecules, and between pro-atherogenic and anti-coagulant 
states [14]. This pathological condition is characterized by one 
or more of the following features: impaired NO 
bioavailability, increased oxidative stress, enhanced cell 
turnover, increased production of growth factor, 
over-expression of adhesion molecules and inflammatory 
genes, hemodynamic deregulation and increased 
permeability of the cell layer [15].  
Several factors contribute to the outcome of endothelial 
dysfunction, for example high levels of LDL cholesterol, 
glucose, insulin, triglycerides and omega-6 to omega-3 ratio, 
low concentration of HDL and Vitamin D and all wrong life 
habits [16]. Most of these factors are related to diet. This is 
why a dietary approach may reduce the risk of cardiovascular 
disease, also by affecting and ameliorating the endothelial 
function.  
The endothelium is an important target for CVDs therapy, 
since it is rapidly exposed to systemically administered 
agents establishing a link with the underlying tissues [1]. 
Recent studies have shown a strong correlation between 
endothelial progenitor cells levels and cardiovascular risk; 
these cells have been indeed proposed as novel biomarker of 
endothelial function [17]. Accumulated evidences suggest that 
a balance between the damaged effects of cardiovascular risk 
factors and the ability of circulating progenitors to improve 
endothelial function, affects the cardiovascular risk [17-19].  
Decreased amounts of EPCs are correlated with 
atherosclerotic disease progression and increased 
cardiovascular risk, thus supporting an important role for 
endogenous vascular repair in modulating the clinical 
outcome of CAD. Age, sex, exercise, smoking, lipid profile, 
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insulin resistance, inflammation, hypertension and genetic 
background have emerged as important factors correlated 
with EPCs number and function [20]. So, monitoring the 
levels of circulating EPCs as a surrogate biological marker 
might be specifically useful to identify novel approaches to 
enhance vascular repair capacity and thereby affect the 
progression of cardiovascular diseases [21].  
Several studies have shown the beneficial effect of drugs 
on EPCs, often isolated from patients with cardiovascular 
disease (CVD). 
Treatment with statins, for example, leads to an increase in 
both number and functional activity of EPCs, thus 
contributing to the re-endothelization of damaged vessels [22]; 
moreover, a recent study of Fadini and colleagues showed 
that a brief statin withdrawal increases circulating EPCs and 
functional proangiogenic cells in T2D patients [23]. Treatment 
with sitagliptin, a dypeptidyl peptidase-4 inhibitor, increases 
the number of circulating CD34+CXCR4+cells, candidate 
markers for endothelial progenitor cells (EPCs) definition, by 
approximately 2-fold in patients with T2D [24]. Exendin-4, a 
human glucagon-like peptide 1 analogue, was shown to 
protect against ischemia in obese mice under hypoxic stress 
by enhancing angiogenesis capacity and circulating EPCs 
levels [25].  
Experimental evidence demonstrated an induction, by 
angiotensin-II, of senescence in endothelial progenitor, 
through an increase of oxidative stress; starting from these 
results, recent studies have shown the beneficial effect of the 
ACE inhibitors and also of angiotensin receptor blockers, on 
the mobilization and functional status of EPCs in conditions 
associated with vascular endothelial damage [26, 27]. Spigoni 
and colleagues demonstrated that also pioglitazone, an 
insulin-sensitizing agent currently used in type 2 diabetic 
patients, is able to increase both viability and tubule 
formation capacity of endothelial progenitor cells isolated 
from pre-diabetic patients (patients with IGT impaired 
glucose tolerance) [28]. Continuous infusion of insulin in T1D 
patients enhances EPCs number, suggesting a novel 
mechanism of vascular damage by glucose fluctuations [29]. 
Even treatment with erythropoietin seems to have 
beneficial effects on the functional properties of EPCs in 
both animals and humans [30], while a study of Iwakura and 
colleagues showed an increase in the mobilization of EPCs 
after treatment with estradiol [31]. 
Endothelial health maintenance: the nutraceutical 
approach  
An "unhealthy" diet is one of the main causes of increased 
atherosclerotic cardiovascular disease in the industrialized 
countries. There is indeed a great interest in the potential 
cardiovascular protective effects of "nutraceuticals", 
food-derived substances that seems able to exert beneficial 
effects on health. Whether the endothelial dysfunction plays 
an important role in development and progression of 
atherosclerosis, the characterization of the endothelial effects 
of several nutraceuticals may provide important insights into 
their potential role in cardiovascular prevention [32]. 
Several nutrients and phytochemicals in fruits and 
vegetables, including fiber, vitamins and antioxidant, could 
be independently or jointly responsible for the reduction in 
cardiovascular risk [33]. Since endothelial dysfunction is 
considered a risk factor for CVDs and an independent 
prognostic marker, maintaining correct endothelial function 
with dietary approaches has became a key therapeutic goal 
[34]. 
Dietary nitrite supplementation, for example, has been 
suggested to treat vascular aging, by reducing oxidative 
stress and inflammation thus preventing CVDs [35], omega-3 
fatty acid supplementation improves endothelial health 
reducing CVD risk [36], while L-arginine, a precursor of NO 
synthesis, is able to normalize endothelial function when 
long-term administered [37]. Since oxidative stress is one of 
the major risk factor of endothelial dysfunction, several 
studied were performed using antioxidant molecules in 
healthy or ill subjects. 
Antioxidant vitamin E and C supplementation showed an 
improvement of endothelial function in non-obese T2D 
subjects [38], while vitamin D intake improved vasculature 
and kidney function in postmenopausal women [39]. Lipoic 
acid, a naturally occurring antioxidant, reduced serum 
glucose in diabetic patients [40] and enhanced endothelial 
function in subjects with metabolic syndrome [41].  
Since EPCs play an essential role during endothelial 
homeostasis and repair, a healthy diet is probably able to 
affect endothelium health also by modulating the number and 
the functional activity of endothelial progenitors; active and 
functional EPCs are indeed able to better and faster 
counteract to all external stimuli and risk factors. 
 Ginkgo Biloba, for instance, showed in vitro beneficial 
effects on endothelial progenitors: treatment with its extract 
inhibits EPCs senescence, through augmentation of 
telomerase activity [42]. Moreover, folic acid supplementation 
modulates EPCs transcriptome in diabetic subjects [43]. Fish 
oil intake, in a different study, revealed no significant effect 
on vascular health [44], while a recent research showed 
Stem Cell & Translational Investigation 2015; 2: e949. doi: 10.14800/scti.949; © 2015 by R. Russo, et al. 
http://www.smartscitech.com/index.php/scti 
 
Page 4 of 9 
 
beneficial actions a of fish-oil supplementation on cellular 
markers of endothelial function: increased numbers of EPCs 
and reduced numbers of EMPs (endothelial microparticles), 
thus favoring the maintenance of endothelial integrity [45]. 
Recent studies focused on polyphenols, a large class of 
natural compounds abundant in fruits, vegetables and spices. 
Several researches [46, 47] have found an inverse correlation 
between polyphenols assumption and CVD risk and 
mortality. In fact such healthy effects may explain the 
protective action on CVD exerted by food and beverages rich 
in polyphenols such as wine and tea or fruit juice [48, 49]. The 
beneficial effects of polyphenols are mediated by many 
biochemical pathways; these compounds indeed improve 
endothelial function and increase NO release, modulate 
inflammation and lipid metabolism, protect against 
atherothrombotic events and platelet aggregation, and 
increase antioxidant status [33]. All these functions lead to 
normalization of vascular tone and also an overall 
antihypertensive effect [50]. 
Epicatechin and catechin, two of the major and most 
investigated polyphenols, recently showed beneficial effects 
on patients with peripheral artery disease, by modulating 
endothelial activation induced by platelets, thus preventing 
atherosclerosis development [51]. A member of catechin 
family, epigallocatechin gallate, the most abundant 
polyphenol in green tea, seems to exert an insulin-mimetic 
action that counteract endothelial dysfunction and ameliorate 
insulin resistance in liver and skeletal muscle [52]. Since the 
main actions of polyphenols are based on their scavenging 
ability, recent both in vivo and in vitro studies focused on 
their protection from oxidative stress. Campos and 
colleagues, for example, showed that lemon grass 
polyphenols protect HUVECs (human umbilical vein 
endothelial cells) from oxidative stress induced by several 
stimuli [53]; another study analyzed the effects of olive oil 
polyphenols using an in vitro model that simulates T2D 
(ECV304 cells) and demonstrated that such compounds 
protect against endothelial dysfunction induced by high 
glucose and free fatty acids through modulation of nitric 
oxide and endothelin-1 [54]. Although several polyphenols are 
well known nowadays, the most famous is still resveratrol, 
an important antioxidant in red wine, which probably 
contributes to the potential of this beverage to prevent 
cardiovascular diseases. Wang and collaborators recently 
showed that this compound not only increases number and 
activity of endothelial progenitor cells, but also delays their 
senescence by enhancing telomerase activity [55, 56].  
In recent years, many in vivo studies have been carried 
out, based on polyphenols-enriched diet; an improvement of 
endothelial function was shown in diabetic mice [57], in 
hyperlipidemic rats [58] and also in dyslipidemic pigs [59].  
Although the great interest on the single bioactive food 
component, such as resveratrol in wine, flavonoids in tea or 
allicin in garlic, one of the main challenge of agro-alimentary 
research is to understand the effective action of whole food 
on human and animal health, to further advice the 
composition of an healthy diet [60]. In order to fulfill this 
need, several clinical studies have been carried out to identify 
the different effects of single component and whole food, for 
example lycopene vs tomato [61] or resveratrol vs red wine 
[62], with controversial results. Therefore further studies need 
to be carried out to fully understand all individual and 
synergistic effects of food components. 
Fermented food: a new class of nutraceuticals? 
Shortly, the fermenting process can be defined as a set of 
chemical reactions that transform substances into simpler and 
more easily digestible compounds that activates 
digestive enzymes and friendly bacteria. This process has 
been always employed to get a new class of food, rich in 
bioactive compounds, the fermented food, which recently 
showed interesting roles in cardiovascular prevention. 
Consumption of traditional fermented legumes, for 
example, has shown protective effects against CVD [63]; 
indeed, fermentation of legumes brings several advantages 
since it reduces the non-nutritional factors, improves nutrient 
digestibility and decreases their allergenicity [64]. This 
technological process also affects the biological functionality 
of legumes, as microbial enzymes perform the bioconversion 
of polyphenols into more active compounds [65, 66]. A recent 
study showed that fermentation enhances the content of 
bioactive compounds in kidney bean extracts, thus 
encouraging the consumption of fermented legumes as a 
source of healthy substances [66]. 
Phaseulus Vulgaris species, known to decrease both 
LDL-cholesterol and oxidative stress, well-known risk 
factors for CVD, and able to exert beneficial effects on 
short-term satiety and weight loss [67], demonstrated 
antistress and antioxidant effect in vivo when fermented [68]. 
La Marca and colleagues showed that an extract obtained 
from a fermented powder of bean (Phaseolus vulgaris L.) 
tested on primary cultures of rat hepatocytes was able to 
regulate antioxidant and detoxifying enzymes through the 
Nrf2 pathway, inhibiting NF-kB activation and reducing 
H2O2-induced endoplasmic reticulum (ER) stress [69].  
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Recently, a Monascus-fermented rice extract was found to 
protect endothelial function through lipid-lowering, 
anti-inflammatory and antioxidative mechanisms; this extract 
also affects C-reactive protein concentration [70]. 
Black tea, the fermented type of tea, was recently shown 
to protect against endothelial dysfunction through oxidative 
and endoplasmic reticulum stress modulation [71]. 
Moreover, HPLC analysis of samples obtained from 
fermentation procedures showed that the level of major tea 
catechins epigallocatechin gallate (EGCG) and epicatechin 
gallate (ECG) dropped increasingly to about 1/3 in the final 
product [72]. Also in kidney bean extracts HPLC analysis 
showed a huge increase of total bioactive compounds, in 
particular non-anthocyanin phenolic compounds, after 
fermentation [66]. 
Epidemiological evidences demonstrate that moderate 
alcohol consumption, in particular of fermented beverages 
such as wine and beer, reduces the risk of morbidity and 
mortality from CVDs [73]; two recent studies suggest an 
involvement of endothelial progenitor cells in these healthy 
effects. Indeed, Hang and colleagues, showed an 
improvement of number and functional activity of EPCs after 
red wine intake trough the enhancement of nitric oxide 
bioavailability [74]. In a further study, Chiva-Blanch and 
colleagues, compared the effects of moderate consumption of 
beer, non-alcoholic beer and gin on the number of circulating 
EPCs and EPC-mobilizing factors in subjects at high 
cardiovascular risk [75]; since non-alcoholic fraction of beer 
positively affects EPCs number, the authors suggested that 
the greater cardiovascular protection conferred by fermented 
beverage (such as beer or wine) is due to their high 
polyphenolic content. 
A recent in vivo study, showed an augmentation of EPCs 
in healthy subjects after supplementation with a food 
supplement, Stem-Kine [76], produced by fermentation of a 
combination of green tea, astralagus and goji berry extracts.  
Another fermentation product, an extract of Zijuan Pu-erh 
tea, revealed an elevated antioxidant activity in vascular 
endothelial cells exposed to oxidative stress probably related 
to a different concentration of bioactive compounds such as 
polyphenols [77]. The same extract showed antiangiogenetic 
effects on HUVECs and anticancer activity on HT-29 cells 
[78]. 
Such evidences suggest a positive effect of food 
fermentation on endothelial progenitors number and 
functions. 
In an our study EPCs treatment with a fermented grain, 
Lisosan G, increased not only viability but also cell function 
through the enhancement of antioxidative defenses, 
involving Nrf-2 pathway [79]. Whole grain cereals contain a 
lot of nutrients and bioactive substances that have 
health-promoting effects and epidemiological studies 
extensively demonstrated that whole grains consumption 
correlates with a reduced risk of type 2 diabetes and 
cardiovascular diseases [80]. 
 In our work, we explored the effects of Lisosan G. This 
product not only presents the above mentioned features of 
cereals, but is also enriched in bioactive compounds such as 
flavonoids, phenolic components and alpha-lipoic acid, since 
it derives from a fermentation process [81]. There, we 
evaluated the viability and cell function of endothelial 
progenitors and showed beneficial effects on both properties.  
Lipoic acid (LA) is a natural antioxidant synthesized in the 
mitochondria which is able to directly scavenge ROS, chelate 
metals and react with, and regenerate, other antioxidants such 
as Vitamins E and C [82]; it also showed anti-inflammatory 
properties and is soluble both in fat and water which allows it 
to travel to and to enter all parts of the body [83]. Recent 
studies proposed LA as protective agent against CVDs 
outcome and progression, since it reinforces natural defenses 
and resistance to several types of stressors [84, 85]. Although 
the mechanisms underlying these protective effects remain 
still unclear, a recent study of Ying and colleagues [86] 
demonstrated that LA activates eNOS in endothelial cells in 
a PI3-kinase/Akt-dependent manner, thus counteracting 
endothelial dysfunction.  
We further suggest that Lisosan G ability to increase 
functional properties of this cardiovascular disease marker, is 
related to its components, such as linoleic and linolenic 
acids, alpha-lipoic acid, flavonoids and phenols. 
Conclusions 
The area of nutritional modulation of the stem cell 
compartment seems to offer significant benefit in treatment 
of a wide variety of cardiovascular, metabolic and 
degenerative diseases.  
Fruits, cereals, legumes and vegetables are currently 
recognized as a source of antioxidant compounds that 
ameliorate EPCs viability and function, thus preventing 
endothelial dysfunction. 
However, given the commercial pressures associated with 
this largely unregulated field, we suggest that detailed 
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scientific investigations had to be performed before disease 
associated claims are released by the scientific community. 
One area of recent interest in the biomedical field has been 
that of functional foods and nutraceuticals. While it is known 
that alteration of diet may modulate vascular responses, to 
our knowledge, little work as been reported to date on 
fermented foods and their capacity in improving levels and 
functions of circulating EPCs.  
Fermentation is known to increase the bioavailability of 
minerals, proteins, peptides, antioxidants, flavanols and other 
organic molecules and several studies reported an association 
between fermented foods and human endothelial 
functionality and in particular EPC levels and function. 
The mechanisms involved in these processes may be 
associated with a reduced production of free radicals and less 
oxidative stress, due to the protective effect of the 
antioxidant components of a fermented food rich diet. 
In conclusion, consumption of fermented foods, enriching 
the diet of antioxidants thus reducing oxidative stress, 
improve the regenerative capacity of the endothelium as a 
result of a better balance between damage and repair. 
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